C12Y 304/22014
Actinidain
Official title: Actinidain (3.4.22.14)
C12Y304/22014 (Actinidain) appears on 2 US grants and 9 published applications in this corpus.
Search patents in C12Y- Granted patents
- 2
- Published applications
- 9
- Assignees
- 4
- Inventors
- 14
- Latest grant
- 27 Dec 2016
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 2 | 1 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 2 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 2 |
By publication year.
Recent patents
- Compositions for breakdown of gluten proteins28 Aug 2025US 2025/0268995 A1
- Methods for treating respiratory diseases9 Jan 2025US 2025/0009856 A1Mucpharm Pty Ltd
- Formulations containing mucin-affecting proteases14 Jan 2021US 2021/0008180 A1
- Clean label wheat protein isolate16 May 2019US 2019/0142029 A1Manildra Milling Corporation
- Novel compositions for the treatment of cancer16 May 2019US 2019/0142911 A1
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.